EUVIMEDEUVIMED entdecken
Crossref

Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation

Yuqin Zang, Ruqian Zhao, Tao Wang, Yueqian Gao, Lingli Chen, Shiqi Liu, Yingmei Wang, Fengxia Xue

Molecular Medicine Reports · 2023

DOI: 10.3892/mmr.2023.13002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2023. Verfasst von Yuqin Zang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the most common gynecologic malignancy worldwide, cervical cancer (CC) is a serious hazard to health. Therefore, the present study aimed to identify the key genes in CC progression using integrated bioinformatics analysis and experimental validation. The mRNA microarray GSE63514 and microRNA (miRNA) microarray GSE86100 were obtained from the Gene Expression Omnibus database, and the differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) in the progression of CC were identified. Thereafter, GO and KEGG functional enrichment analysis, protein‑protein interaction (PPI) network and significant subnetworks construction, and miRNA‑target regulatory network construction were performed. Based on the results of integrated bioinformatics analysis, the DEGs structural maintenance of chromosomes 4 (SMC4), ATPase family, AAA domain‑containing 2 (ATAD2) and DNA polymerase θ (POLQ) were identified as hub genes in the PPI network and were involved in the first significant subnetwork. In addition, these DEGs were predicted to be regulated by miR‑106B, miR‑17‑5P, miR‑20A and miR‑20B, which were identified as DEMs. Of note, SMC4 and ATAD2 are tumor‑promotors in CC. In the present study, small interfering (si)RNAs were used to knock down POLQ expression. Cell Counting Kit‑8, Transwell, cell cycle and apoptosis analyses revealed that the downregulation of POLQ restrained cell proliferation, migration and invasion, and promoted apoptosis and the arrest of the cell cycle in the G2 phase. In conclusion, POLQ, which may have a close interaction with SMC4 and ATAD2, may serve a vital role in the progression of CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsMicroRNAsHumansFemaleGene Expression ProfilingComputational BiologyGene Regulatory NetworksGene Expression Regulation, NeoplasticATPases Associated with Diverse Cellular ActivitiesDNA-Binding ProteinsDNA Polymerase theta

Stichwörter der Autor:innen

DNA polymerase θPOLQbioinformatics analysiscervical cancermicroRNA‑target regulatory networkprotein‑protein interaction

Substanzen

MicroRNAsATPases Associated with Diverse Cellular ActivitiesDNA-Binding ProteinsDNA Polymerase thetaATAD2 protein, human

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China.

Zitieren

APA

Zang, Y., Zhao, R., Wang, T., Gao, Y., Chen, L., Liu, S., Wang, Y., & Xue, F. (2023). Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2023.13002

Vancouver

Zang Y, Zhao R, Wang T, Gao Y, Chen L, Liu S, et al. Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation. Molecular Medicine Reports. 2023. doi:10.3892/mmr.2023.13002

BibTeX
@article{Zang2023,
  author = {Zang, Yuqin and Zhao, Ruqian and Wang, Tao and Gao, Yueqian and Chen, Lingli and Liu, Shiqi and Wang, Yingmei and Xue, Fengxia},
  title = {Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation},
  journal = {Molecular Medicine Reports},
  year = {2023},
  doi = {10.3892/mmr.2023.13002}
}
Kostenlos starten →